FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2992130730> ?p ?o ?g. }

• W2992130730 endingPage "106050" @default.
• W2992130730 startingPage "106050" @default.
• W2992130730 abstract "Advanced melanoma, one of the most lethal forms of skin cancer, remains a difficult condition to treat, despite the substantial scientific progression in cancer treatment. Oncolytic virotherapy (OV), either alone or combined with immune checkpoint inhibitors (ICIs), has often been administrated in an attempt to cure this malignancy. However, the clinical outcomes dramatically vary among different reports.In this study, we performed a meta-analysis to evaluate the clinical efficacy and safety profile of OV, combined with ICIs in some cases, in advanced melanoma patients. The original clinical studies were identified based on the online query in PubMed, Cochrane, and Web of Science before December 30, 2018.A total of 18 publications involving 1472 patients were included for the final meta-analysis. The data concerning objective response rate (ORR) and incidence rate of severe immune-related adverse events (irAEs) were extracted accordingly from the text or supplementary materials. The results illustrated that a single treatment of OV could generate a 25% ORR for advanced melanoma, and the ORR could be improved to 45% if combined with ICIs. Further analysis demonstrated that the introduction of ICIs in OV could increase the incidence rate of severe irAEs (AE ≥ 3) from 12% to 39%. However, the rate attributed to OV remains at 12% in the combination group.The clinical efficacy of OV can be significantly improved by ICIs even though more onerous burden will be exerted simultaneously on the safety profile." @default.
• W2992130730 created "2019-12-13" @default.
• W2992130730 creator A5028507462 @default.
• W2992130730 creator A5048976159 @default.
• W2992130730 creator A5088080779 @default.
• W2992130730 date "2020-01-01" @default.
• W2992130730 modified "2023-09-26" @default.
• W2992130730 title "Oncolytic virotherapy, alone or in combination with immune checkpoint inhibitors, for advanced melanoma: A systematic review and meta-analysis" @default.
• W2992130730 cites W1549566105 @default.
• W2992130730 cites W1977890900 @default.
• W2992130730 cites W1978558644 @default.
• W2992130730 cites W2001075274 @default.
• W2992130730 cites W2082150850 @default.
• W2992130730 cites W2096322385 @default.
• W2992130730 cites W2109274792 @default.
• W2992130730 cites W2114363080 @default.
• W2992130730 cites W2150755101 @default.
• W2992130730 cites W2174665558 @default.
• W2992130730 cites W2207677213 @default.
• W2992130730 cites W2217327485 @default.
• W2992130730 cites W2427476638 @default.
• W2992130730 cites W2494461917 @default.
• W2992130730 cites W2515494400 @default.
• W2992130730 cites W2518538521 @default.
• W2992130730 cites W2595403257 @default.
• W2992130730 cites W2596479132 @default.
• W2992130730 cites W2602107020 @default.
• W2992130730 cites W2740867080 @default.
• W2992130730 cites W2750781282 @default.
• W2992130730 cites W2753432434 @default.
• W2992130730 cites W2753913509 @default.
• W2992130730 cites W2754454631 @default.
• W2992130730 cites W2756324556 @default.
• W2992130730 cites W2763265527 @default.
• W2992130730 cites W2764266371 @default.
• W2992130730 cites W2769213797 @default.
• W2992130730 cites W2772677509 @default.
• W2992130730 cites W2783137027 @default.
• W2992130730 cites W2790846508 @default.
• W2992130730 cites W2801821552 @default.
• W2992130730 cites W2802513889 @default.
• W2992130730 cites W2890744606 @default.
• W2992130730 cites W2891670268 @default.
• W2992130730 cites W2892258519 @default.
• W2992130730 cites W2897056135 @default.
• W2992130730 cites W2904269909 @default.
• W2992130730 cites W2905199128 @default.
• W2992130730 cites W2907791470 @default.
• W2992130730 cites W2909014223 @default.
• W2992130730 cites W2924471100 @default.
• W2992130730 cites W2945590213 @default.
• W2992130730 cites W2953473534 @default.
• W2992130730 cites W2958271298 @default.
• W2992130730 cites W4211223138 @default.
• W2992130730 cites W4211238487 @default.
• W2992130730 cites W936556308 @default.
• W2992130730 doi "https://doi.org/10.1016/j.intimp.2019.106050" @default.
• W2992130730 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31812724" @default.
• W2992130730 hasPublicationYear "2020" @default.
• W2992130730 type Work @default.
• W2992130730 sameAs 2992130730 @default.
• W2992130730 citedByCount "9" @default.
• W2992130730 countsByYear W29921307302020 @default.
• W2992130730 countsByYear W29921307302021 @default.
• W2992130730 countsByYear W29921307302022 @default.
• W2992130730 crossrefType "journal-article" @default.
• W2992130730 hasAuthorship W2992130730A5028507462 @default.
• W2992130730 hasAuthorship W2992130730A5048976159 @default.
• W2992130730 hasAuthorship W2992130730A5088080779 @default.
• W2992130730 hasConcept C120665830 @default.
• W2992130730 hasConcept C121332964 @default.
• W2992130730 hasConcept C121608353 @default.
• W2992130730 hasConcept C126322002 @default.
• W2992130730 hasConcept C143998085 @default.
• W2992130730 hasConcept C177713679 @default.
• W2992130730 hasConcept C197934379 @default.
• W2992130730 hasConcept C2777658100 @default.
• W2992130730 hasConcept C2779399171 @default.
• W2992130730 hasConcept C502942594 @default.
• W2992130730 hasConcept C61511704 @default.
• W2992130730 hasConcept C71924100 @default.
• W2992130730 hasConcept C82210918 @default.
• W2992130730 hasConcept C95190672 @default.
• W2992130730 hasConceptScore W2992130730C120665830 @default.
• W2992130730 hasConceptScore W2992130730C121332964 @default.
• W2992130730 hasConceptScore W2992130730C121608353 @default.
• W2992130730 hasConceptScore W2992130730C126322002 @default.
• W2992130730 hasConceptScore W2992130730C143998085 @default.
• W2992130730 hasConceptScore W2992130730C177713679 @default.
• W2992130730 hasConceptScore W2992130730C197934379 @default.
• W2992130730 hasConceptScore W2992130730C2777658100 @default.
• W2992130730 hasConceptScore W2992130730C2779399171 @default.
• W2992130730 hasConceptScore W2992130730C502942594 @default.
• W2992130730 hasConceptScore W2992130730C61511704 @default.
• W2992130730 hasConceptScore W2992130730C71924100 @default.
• W2992130730 hasConceptScore W2992130730C82210918 @default.
• W2992130730 hasConceptScore W2992130730C95190672 @default.
• W2992130730 hasLocation W29921307301 @default.

• next